Scribe Therapeutics, Inc.
AI summary Insiders and major institutional funds purchase shares in Scribe Therapeutics' initial public offering.
- Research score
- 61
- AI adjustment
- -11
Research score, not a recommendation.
Market data
Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.
–
partial data Price history is incomplete; missing inputs count as neutral in the score.
Why this score
Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.
Why are they buying?
AI · ipo_offering · catalyst credible · documentedInsiders and major stakeholders acquired shares as part of Scribe Therapeutics' initial public offering and concurrent open-market transactions following the company's debut on the public market.
Scribe Therapeutics priced its upsized initial public offering at $15.00 per share, raising $155.5 million in gross proceeds before trading higher in its market debut.
Stock Price & Insider Purchase History
Daily close price with open-market insider purchases plotted over time
Loading price history…
| Date | Insider | Role | Shares | Price | Value | Flags | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-24 → 2026-07-28 | Aghazadeh Behzad history of Aghazadeh Behzad's purchases | Director | 2,391,238 | $15.16 avg | $36.3M | ||
| 2026-07-24 | Aghazadeh Behzad | 50,000 | $22.31 | $1.1M | SEC filing for Aghazadeh Behzad (opens in a new tab) | ||
| 2026-07-24 | Aghazadeh Behzad | 2,333,333 | $15.00 | $35.0M | SEC filing for Aghazadeh Behzad (opens in a new tab) | ||
| 2026-07-28 | Aghazadeh Behzad | 7,905 | $18.25 | $144.3K | SEC filing for Aghazadeh Behzad (opens in a new tab) | ||
| 2026-07-27 | ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases | Director | 1,000,000 | $15.00 | $15.0M | SEC filing for ORBIMED ADVISORS LLC (opens in a new tab) | |
| 2026-07-27 | GORDON CARL L history of GORDON CARL L's purchases | Director | 1,000,000 | $15.00 | $15.0M | SEC filing for GORDON CARL L (opens in a new tab) | |
| 2026-07-27 | Andreessen Marc L history of Andreessen Marc L's purchases | 10% owner | 333,333 | $15.00 | $5.0M | SEC filing for Andreessen Marc L (opens in a new tab) | |
| 2026-07-23 | Lucas Svetlana history of Lucas Svetlana's purchases | Other C-suite | 3,000 | $15.00 | $45.0K | SEC filing for Lucas Svetlana (opens in a new tab) | |
| 2026-07-23 | Parrot David history of Parrot David's purchases | CFO | 1,333 | $15.00 | $20.0K | SEC filing for Parrot David (opens in a new tab) | |
| Total | $71.3M | ||||||
What happened next
A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
After this run became a cluster: 21 days +55.6%63 days –126 days –